GlassScriptPhysician profile
Wei-Ning E Liu
NPI 1598261620
$5,640.40
in general payments reported to CMS, 2019-2025
37 companies · $1,080 in 2025
The $1,080 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.59 · 2021: $184 · 2022: $1,324 · 2023: $1,410 · 2024: $1,631 · 2025: $1,080.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,120.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,267.28 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $512.86 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $484.55 | 2022-2025 | |
| Abbvie INC. | $407.50 | 2021-2025 | |
| Abbott Laboratories | $351.02 | 2022-2025 | Freestyle Libre 3 |
| Amgen INC. | $300.93 | 2022-2025 | Otezla, Repatha, Evenity |
| Lilly USA, LLC | $256.30 | 2021-2025 | Jardiance, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $195.90 | 2022-2024 | Farxiga, Airsupra |
| Dexcom, INC. | $170.99 | 2023-2025 | Dexcom G6 Transmitter |
| E.R. Squibb & Sons, L.L.C. | $166.73 | 2022-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $138.51 | 2022-2023 | Spravato |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $115.63 | 2022-2025 | Xifaxan, Trulance |
| Xeris Pharmaceuticals, INC. | $114.23 | 2022-2025 | Gvoke Hypopen |
| Glaxosmithkline, LLC. | $100.31 | 2022-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Biohaven Pharmaceutical Holding Company LTD. | $97.41 | 2022 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wei-Ning Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.